Loading the latest PSX data…
Loading the latest PSX data…
Hoechst Pakistan LimitedShariah-compliant
+21.18 (+0.53%) today
Market closed, last update Nov 17, 2026 4:35 PMThe Hoechst Pakistan share price was Rs 4,017.76 (+0.53%) at the last PSX update (Nov 17, 2026 4:35 PM). HPL is a pharmaceuticals stock with a market value of Rs 38.8bn.
Last session's range17 Nov 2026
3,982.1094% up the range4,019.98
52-week range
3,602.0032% up the range4,889.99
Price limits (circuit breakers)
3,596.9253% up the range4,396.24
+0.4% over 6M(KSE-100 +4.5%)
Daily bars from PSX's end-of-day market summary. Prices before a bonus issue, right issue or split are adjusted so the chart stays continuous; cash dividends are not taken out.
Full-screen HPL chart with levelsDownload HPL price history (CSV)Compare HPL with GLAXO
From daily closes to 2026-11-17. A description of the trend, not a forecast.
Trend reading
Uptrend
Down4 up · 1 down signalsUp
| S2 | S1 | Pivot | R1 | R2 |
|---|---|---|---|---|
| 3,968.73 | 3,993.25 | 4,006.61 | 4,031.13 | 4,044.49 |
+518.1% over 5 years
Monthly closing prices from the PSX Data Portal, since 2003. Earlier prices are adjusted for bonus shares and splits (about 10% bonus or ex-dividend fall, 2013-04; about 10% bonus or ex-dividend fall, 2024-07) so the line shows the value of one original share.
| Announced | Period | Payout | Profit after tax | EPS (Rs) | Books close |
|---|---|---|---|---|---|
| 21 Oct 15:42 | 1st quarter to 30 Sept | None | – | 291.07 | – |
| 21 Oct 15:41 | 1st quarter to 30 Sept | None | Rs 2,809.9m | 291.34 | – |
| 20 Aug 15:50 | Half year to 30 Jun | None | – | 227.20 | – |
| 20 Aug 15:50 | Full year to 30 Jun | Second interim cash dividend 800% | Rs 2,195.6m | 227.65 | 3 Sept – 4 Sept |
| 8 May 17:02 | – to – | None | – | – | 15 May – 21 May |
| 22 Apr 15:54 | 1st quarter to 31 Mar | None | – | 73.71 | – |
| 22 Apr 15:54 | 1st quarter to 31 Mar | None | Rs 720.6m | 74.71 | – |
| Measure | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Sales growth | +15.6% | +25.2% | +15.1% | – |
| Profit growth | +56.7% | +414.7% | +116.3% | – |
| EPS growth | +56.7% | +414.7% | +116.4% | – |
| Net margin | 9.4% | 6.9% | 1.7% | 0.9% |
| Measure | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|---|
| Sales growth | −6.0% | – | – | – |
| Profit growth | −29.8% | – | – | – |
| EPS growth | −29.8% | – | – | – |
| Net margin | 7.9% | 16.4% | 9.4% | 10.6% |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Sales | Rs 30.9bn | Rs 26.7bn | Rs 21.4bn | Rs 18.6bn |
| Profit after tax | Rs 2.9bn | Rs 1.9bn | Rs 361m | Rs 167m |
| Earnings per share (Rs) | 301.67 | 192.56 | 37.41 | 17.29 |
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|---|
| Sales | Rs 7.8bn | Rs 9.0bn | Rs 7.7bn | Rs 8.3bn |
| Profit after tax | Rs 614m | Rs 1.5bn | Rs 721m | Rs 876m |
| Earnings per share (Rs) | 63.70 | 152.94 | 74.71 | 90.79 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Gross margin | 36.5% | 31.5% | 25.9% | 26.2% |
| Net margin | 9.4% | 6.9% | 1.7% | 0.9% |
| EPS growth | 56.7% | 414.7% | 116.4% | -81.6% |
| PEG | 0.25 | 0.04 | 0.28 | -0.68 |
Rupee amounts from PSX filings (thousands converted to Rs m/bn). Data by Capital Stake via the PSX Data Portal; standardised, so it can differ from the annual report. Latest quarter (Q3 2026) EPS fell 29.8% from the same quarter a year earlier.
| Measure | HPL | Sector median | Reading |
|---|---|---|---|
| P/E | 11.1 | 12.3 | Cheaper than peers |
| Dividend yield | 6.9% | 4.7% | Above peers |
| Net margin | 9.4% | 8.8% | Above peers |
| EPS growth | +56.7% | +28.2% | Above peers |
| 1-year return | −2.7% | −14.9% | Above peers |
Sector P/E check. At the sector's median P/E of 12.3, last year's EPS of Rs 301.67 would price HPL at about Rs 3,722.96 (−7% from today). A rough yardstick only: sectors hold very different businesses, and the market prices future profits, not last year's.
Estimate a fair value for HPL (Graham, Lynch, DCF)HPL pivot levels
Ratios as published on the PSX Data Portal (standardised by Capital Stake), latest financial year on the right.
Work out your HPL dividend income after tax
| Announced | Period to | Payout | Cash per share | Books closed |
|---|---|---|---|---|
| 20 Aug 2026 | 30 Jun 2026 | Second interim cash dividend 800% | Rs 80.00 | 3 Sept 2026 – 4 Sept 2026 |
PSX quotes payouts as a percentage of face value; cash per share assumes the usual Rs 10 face value. You get the dividend if you own the shares before the books close.
Market value
7th of 18
Rs 38.8bn
P/E (cheapest first)
4th of 13
11.1
Dividend yield
1st of 7
6.9%
1-year return
4th of 15
-2.7%
EPS growth
4th of 15
56.7%
Net margin
8th of 16
9.4%
| GLAXOGlaxoSmithKline Pakistan Limited | Rs 106.1bn | −1.89% | 9.7 | 6.1% | −15.4% | 87 |
| ABOTAbbott Laboratories (Pakistan) Limited | Rs 98.5bn | +0.18% | 10.6 | 4.4% | −7.6% | 81 |
| HALEONHaleon Pakistan Limited | Rs 79.8bn | −1.15% | 12.2 | 3.6% | −16.6% | 67 |
| HINOONHighnoon Laboratories Limited | Rs 51.1bn | +0.89% | 12.4 | 5.4% | −14.3% | 78 |
| SEARLThe Searle Company Limited | Rs 46.6bn | −0.37% | 12.0 | – | −23.6% | 53 |
| AGPAGP Limited | Rs 43.2bn | −0.84% | 24.1 | 5.1% | −18.3% | 49 |
| HPLThis stock · Hoechst Pakistan Limited | Rs 38.8bn | +0.53% | 11.1 | 6.9% | −2.7% | – |
| FEROZFerozsons Laboratories Limited | Rs 15.7bn | −0.96% | 22.8 | 1.6% | −9.0% | 39 |
| CPHLCiti Pharma Ltd. | Rs 14.4bn | −0.74% | 17.7 | – | −23.2% | 31 |
| GSKCHGlaxoSmithKline Consumer Healthcare | Rs 14.1bn | −3.13% | – | – | – | – |
| BFBIOBF Biosciences Limited | Rs 12.0bn | −0.60% | 18.2 | – | −10.8% | 45 |
| MACTERMacter International Limited | Rs 11.7bn | −1.08% | 3.7 | – | −27.9% | 52 |
| SAPLSanofi-Aventis Pakistan Limited | Rs 8.4bn | 0.00% | – | – | – | – |
| OTSUOtsuka Pakistan Limited | Rs 5.7bn | +0.79% | 11.6 | – | +39.6% | 65 |
| LIVENLiven Pharma Limited | Rs 5.4bn | +10.00% | – | – | −2.3% | 15 |
Swipe the table sideways for more columns.
No director or substantial-shareholder trades in HPL read from PSX notices yet.
Read automatically (OCR) from the disclosure images companies file with PSX under Regulation 5.6.1(d). A digit can be misread, so check the original notice before relying on a figure. Value = shares × price. Not investment advice. All PSX insider trades
Hoechst Pakistan Limited (the Company) was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 [now Companies Act, 2017 (the Act)]. The shares of the Company are listed on Pakistan Stock Exchange Limited (PSX). The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products.
Where the price sits in its 52-week range
Low 3,602.0032% of the way upHigh 4,889.99
Data: PSX Data Portal (Nov 17, 2026 4:35 PM); company data refreshed 17 Nov; daily bars from PSX market summaries; five-year record from danioPSX research. Logos are trademarks of their owners. Not a recommendation to buy or sell HPL. Official PSX page for HPL